Dexamethasone-(C21-phosphoramide)-[anti-EGFR]: molecular design, synthetic organic chemistry reactions, and antineoplastic cytotoxic potency against pulmonary adenocarcinoma (A549).

导出 LinkOut

翻译打印收藏纠错

作者： Cody P,Coyne ^[1] ; Lakshmi,Narayanan ^[2]

作者单位： Department of Basic Sciences. ^[1] Department of Clinical Sciences, College of Veterinary Medicine, Mississippi State University, Starkville, MS, USA. ^[2]

关键词 EGFR anti-EGFR covalent immunopharmaceuticals dexamethasone organic chemistry reactions selective “targeted” delivery synthesis

主题词腺癌(Adenocarcinoma);抗肿瘤药(Antineoplastic Agents);细胞死亡(Cell Death);细胞增殖(Cell Proliferation);地塞米松(Dexamethasone);剂量效应关系, 药物(Dose-Response Relationship, Drug);药物设计(Drug Design);药物筛选试验, 抗肿瘤(Drug Screening Assays, Antitumor);人类(Humans);肺肿瘤(Lung Neoplasms);构效关系(Structure-Activity Relationship);肿瘤细胞, 培养的(Tumor Cells, Cultured)

DOI 10.2147/DDDT.S102075

PMID 27574398

发布时间 2023-11-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Drug design, development and therapy

2016年10卷

2575-97页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Dexamethasone-(C21-phosphoramide)-[anti-EGFR]: molecular design, synthetic organic chemistry reactions, and antineoplastic cytotoxic potency against pulmonary adenocarcinoma (A549).

Drug design, development and therapy

相似文献

Drug design, development and therapy

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Dexamethasone-(C21-phosphoramide)-[anti-EGFR]: molecular design, synthetic organic chemistry reactions, and antineoplastic cytotoxic potency against pulmonary adenocarcinoma (A549).

Drug design, development and therapy

相似文献

Drug design, development and therapy

相关期刊

检索历史清除